ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

RPRX Royalty Pharma PLC

31.06
0.44 (1.44%)
25 Jan 2025 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 467.76M683.97M653.4M543.61M473.57M567.98M583.49M622.37M
Operating Income 28.33M513.58M363.27M153.52M468.93M-87.92M317.55M803.16M
Pre Tax Income -610.03M509.09M351.34M122.08M717.59M-4.27M194.38M806.36M
Net Income -456.08M340.76M227.63M72.11M494.34M4.78M102M543.99M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -3.71M535.06M372.24M155.06M754.91M36.23M224.01M854.67M
EBITDA 28.33M513.58M363.27M153.52M468.93M-87.92M317.55M803.16M
Year End 31 December 2023 20202020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 02.12B2.29B2.24B2.35B
Operating Income -13.79M1.64B1.41B913.92M1.5B
Pre Tax Income 51.28M1.7B1.24B230.06M1.7B
Net Income 51.28M975.04M619.73M42.83M1.13B
Preferred Dividends 00000
Basic Earnings Per Share (EPS) 0.140.7560.4640.0320.842
EBIT -13.79M1.87B1.38B858.91M1.82B
EBITDA -13.79M1.66B1.43B919.59M1.5B